BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 16378498)

  • 1. Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease.
    Kanwar JR
    Curr Med Chem; 2005; 12(25):2947-62. PubMed ID: 16378498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination.
    Hisahara S; Okano H; Miura M
    Neurosci Res; 2003 Aug; 46(4):387-97. PubMed ID: 12871760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
    Kanwar JR; Kanwar RK; Krissansen GW
    Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?
    Werner P; Pitt D; Raine CS
    J Neural Transm Suppl; 2000; (60):375-85. PubMed ID: 11205156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
    de Toledo JHDS; Fraga-Silva TFC; Borim PA; de Oliveira LRC; Oliveira EDS; Périco LL; Hiruma-Lima CA; de Souza AAL; de Oliveira CAF; Padilha PM; Pinatto-Botelho MF; Dos Santos AA; Sartori A; Zorzella-Pezavento SFG
    Front Immunol; 2020; 11():571844. PubMed ID: 33193354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis.
    Zhang X; Hupperts R; De Baets M
    Immunol Res; 2003; 28(1):61-78. PubMed ID: 12947225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of costimulation in autoimmune demyelination.
    Racke MK; Ratts RB; Arredondo L; Perrin PJ; Lovett-Racke A
    J Neuroimmunol; 2000 Jul; 107(2):205-15. PubMed ID: 10854658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of new therapeutic targets for prevention of CNS inflammation.
    Owens T
    Expert Opin Ther Targets; 2002 Apr; 6(2):203-15. PubMed ID: 12223081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L; Zamvil SS
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate excitotoxicity in a model of multiple sclerosis.
    Pitt D; Werner P; Raine CS
    Nat Med; 2000 Jan; 6(1):67-70. PubMed ID: 10613826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Chu F; Shi M; Zheng C; Shen D; Zhu J; Zheng X; Cui L
    J Neuroimmunol; 2018 May; 318():1-7. PubMed ID: 29606295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Microglial Activity and Enhanced Glutamate Transmission in the Basolateral Amygdala in Early CNS Autoimmunity.
    Acharjee S; Verbeek M; Gomez CD; Bisht K; Lee B; Benoit L; Sharkey KA; Benediktsson A; Tremblay ME; Pittman QJ
    J Neurosci; 2018 Oct; 38(42):9019-9033. PubMed ID: 30185466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.